An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) will report its first quarter 2024 financial results on May 9, 2024, after the market closes. The company aims to improve the lives of individuals with severe medical conditions. A live conference call and webcast will follow the financial report at 4:30 p.m. ET on the same day.
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) comunicherà i risultati finanziari del primo trimestre del 2024 il 9 maggio 2024, dopo la chiusura del mercato. L'obiettivo dell'azienda è migliorare la vita delle persone con gravi condizioni mediche. Seguirà una conferenza telefonica e un webcast in diretta alle 16:30 ET dello stesso giorno.
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) informará sobre sus resultados financieros del primer trimestre de 2024 el 9 de mayo de 2024, después del cierre del mercado. La empresa tiene como objetivo mejorar la vida de las personas con condiciones médicas graves. Habrá una llamada de conferencia y una transmisión web en vivo a las 4:30 p.m. ET el mismo día.
Collegium Pharmaceutical, Inc. (나스닥: COLL)은 2024년 1분기 재무 결과를 2024년 5월 9일, 시장 폐쇄 후에 보고할 예정입니다. 회사는 심각한 의료 조건을 가진 개인의 삶을 개선하고자 합니다. 같은 날 오후 4시 30분 ET에 재무 보고 후 실시간 회의 전화 및 웹캐스트가 진행될 예정입니다.
Collegium Pharmaceutical, Inc. (Nasdaq : COLL) publiera ses résultats financiers pour le premier trimestre 2024 le 9 mai 2024 après la clôture du marché. L'entreprise vise à améliorer la vie des individus souffrant de conditions médicales sévères. Une conférence téléphonique en direct et une webdiffusion suivront le rapport financier à 16h30 HE le même jour.
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) wird am 9. Mai 2024, nach Börsenschluss, die Finanzergebnisse für das erste Quartal 2024 bekannt geben. Das Unternehmen strebt danach, das Leben von Menschen mit schweren medizinischen Zuständen zu verbessern. Ein Live-Telefonkonferenz und Webcast folgen um 16:30 Uhr ET am selben Tag.
Positive
None.
Negative
None.
STOUGHTON, Mass., April 25, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report first quarter 2024 financial results after the market closes on Thursday, May 9, 2024. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET.
Conference Call Information To access the conference call, please dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the “Collegium Pharmaceutical Q1 2024 Earnings Call.” An audio webcast will be accessible from the Investors section of the Company’s website: www.collegiumpharma.com. The webcast will be available for replay on the Company’s website approximately two hours after the event.
About Collegium Pharmaceutical, Inc. Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.
Investor Contact: Christopher James, M.D. Vice President, Investor Relations ir@collegiumpharma.com
When will Collegium Pharmaceutical report its first quarter 2024 financial results?
Collegium Pharmaceutical will report its first quarter 2024 financial results on May 9, 2024, after the market closes.
What is the ticker symbol for Collegium Pharmaceutical?
The ticker symbol for Collegium Pharmaceutical is COLL.
How can I access the live conference call for Collegium Pharmaceutical's Q1 2024 earnings?
To access the conference call, dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and reference the 'Collegium Pharmaceutical Q1 2024 Earnings Call.' An audio webcast will also be available on the Investors section of the Company's website.
collegium pharmaceutical, inc. is a specialty pharmaceutical company developing and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. with a substantial number of patients suffering from chronic pain, collegium is committed to developing and commercializing a portfolio of products that address the growing problems associated with non-medical use, abuse and misuse of prescription products by leveraging the company’s proprietary deterx® technology platform. deterx technology can be used with drugs that are commonly abused such as opioids and amphetamines, as well as drugs that have a narrow therapeutic index that would benefit from protection against misuse such as breaking, crushing, grinding, or dissolving the product. the deterx technology platform is covered by u.s. and international patents and patent applications. collegium’s lead product candidate, xtampza er™, is an abuse-deterrent, ex
